FR2182882A1 - Luteinising hormone releasing hormone prepns with depot - effect - contg diisocyanate-crosslinked gelatin and polyphloretin pho - Google Patents

Luteinising hormone releasing hormone prepns with depot - effect - contg diisocyanate-crosslinked gelatin and polyphloretin pho

Info

Publication number
FR2182882A1
FR2182882A1 FR7309899A FR7309899A FR2182882A1 FR 2182882 A1 FR2182882 A1 FR 2182882A1 FR 7309899 A FR7309899 A FR 7309899A FR 7309899 A FR7309899 A FR 7309899A FR 2182882 A1 FR2182882 A1 FR 2182882A1
Authority
FR
France
Prior art keywords
prepns
diisocyanate
polyphloretin
pho
contg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7309899A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Farbwerke Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG, Farbwerke Hoechst AG filed Critical Hoechst AG
Publication of FR2182882A1 publication Critical patent/FR2182882A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
FR7309899A 1972-03-22 1973-03-20 Luteinising hormone releasing hormone prepns with depot - effect - contg diisocyanate-crosslinked gelatin and polyphloretin pho Withdrawn FR2182882A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2213737A DE2213737A1 (de) 1972-03-22 1972-03-22 Lh-releasing hormon mit protrahierter wirkung

Publications (1)

Publication Number Publication Date
FR2182882A1 true FR2182882A1 (en) 1973-12-14

Family

ID=5839661

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7309899A Withdrawn FR2182882A1 (en) 1972-03-22 1973-03-20 Luteinising hormone releasing hormone prepns with depot - effect - contg diisocyanate-crosslinked gelatin and polyphloretin pho

Country Status (8)

Country Link
AU (1) AU5349873A (pm)
BE (1) BE797166A (pm)
DD (1) DD109305A5 (pm)
DE (1) DE2213737A1 (pm)
FR (1) FR2182882A1 (pm)
IL (1) IL41833A0 (pm)
NL (1) NL7303709A (pm)
ZA (1) ZA731985B (pm)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres

Also Published As

Publication number Publication date
BE797166A (fr) 1973-09-24
AU5349873A (en) 1974-09-26
DE2213737A1 (de) 1973-09-27
IL41833A0 (en) 1973-05-31
ZA731985B (en) 1973-12-19
NL7303709A (pm) 1973-09-25
DD109305A5 (pm) 1974-11-05

Similar Documents

Publication Publication Date Title
AT331507B (de) Photopolymerisierbare masse
FR2075671A5 (fr) Source luminescente d'emission incoherente
GB1329514A (en) Transporting and firing chest for self-propelled projectiles
CA942511A (en) Exhaust emission control
AU463120B2 (en) Adducts of bis-(2-pyridyl-1-oxide) lisulfide with alkaline earth metal salts
FR2182882A1 (en) Luteinising hormone releasing hormone prepns with depot - effect - contg diisocyanate-crosslinked gelatin and polyphloretin pho
BE801932A (fr) Revetement d'un dispositif d'alimentation de haut fourneau
JPS56127392A (en) Manufacture of o-substituted 7beta-amino-3- cephem-3-ol-4-carboxylic acid compound
BE766036A (nl) Door licht verknoopbare lagen
CA930075A (en) Method of manufacturing a semiconductor body
OA03599A (fr) Préparation d'un nouvel antibiotique.
PH9563A (en) Protected decapeptide derivatives of gonadotropin releasing hormone
ZA711214B (en) Dimethyl-dichloro-vinyl phosphate containing insecticide
FI54477C (fi) Foerfarande foer framstaellning av farmakologiskt aktiva 3-bensoyl-benso(b)tiofenderivat
GB1303834A (pm)
CA710830A (en) Disodium and calcium salt of the calcium complex of 2-aminocyclohexyl 2'-aminoethyl ether-n,n,n',n'-tetraacetic acid
AU1756670A (en) An improved capsule for containing an article (divisional of 408,028)
OA03652A (fr) Préparation d'un nouvel antibiotique.
PH10610A (en) Oxazolidine of a tricyclic ketone compound and an optically active ephedrine
TR16706A (tr) 1-hidroksi-2-(1,1-difluoroalkil)-1h-imidazo(4,5-b)piridin bilesiklerinin eterleri ve esterleri
AU426753B2 (en) Time-stop mechanism (divisional of 410,577)
CA851196A (en) Perhydro-1,2,4-thiadiazinedioxides-(1,1)
CA974514A (en) Gelatin hardening agents
CA841570A (en) Curing acceleration of synthetic bonding agents
CA864655A (en) Radioactivity actuated thermoelectric generator 1

Legal Events

Date Code Title Description
ST Notification of lapse